RE: Interesting14 Jun 2025 23:22
For 74 years of age, he's learnt alot 👏
David John Nutt (born 16 April 1951) is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep.[6] He is the chairman of Drug Science, a non-profit which he founded in 2010 to provide independent, evidence-based information on drugs.[7] In 2019 he co-founded the company GABAlabs and its subsidiary SENTIA Spirits which research and market alternatives to alcohol. Until 2009, he was a professor at the University of Bristol heading their Psychopharmacology Unit.[8] Since then he has been the Edmond J Safra chair in Neuropsychopharmacology at Imperial College London and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences there.[9] Nutt was a member of the Committee on Safety of Medicines, and was President of the European College of Neuropsychopharmacology.[10][11][12]